All Stories

  1. Acute interstitial nephritis in patients with inflammatory bowel disease treated with vedolizumab: a systematic review

    Article • Scandinavian Journal of Gastroenterology, April 2024, Taylor & Francis

    Dr Staffan Rosenborg

  2. Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial

    Article • The Lancet Microbe, April 2024, Elsevier

    Dr Staffan Rosenborg

  3. Population pharmacokinetics of apramycin from first-in-human plasma and urine data to support prediction of efficacious dose

    Article • Journal of Antimicrobial Chemotherapy, July 2022, Oxford University Press (OUP)

    Dr Staffan Rosenborg

  4. Pharmacokinetics of methylphenidate and ritalinic acid in plasma correlations with exhaled breath and oral fluid in healthy volunteers

    Article • European Journal of Clinical Pharmacology, November 2019, Springer Science + Business Media

    Dr Staffan Rosenborg

  5. Mesalazine as a cause of fetal anemia and hydrops fetalis

    Article • Medicine, December 2017, Wolters Kluwer Health

    Dr Staffan Rosenborg

  6. High doses of anti-inflammatory drugs compromise muscle strength and hypertrophic adaptations to resistance training in young adults

    Article • Acta Physiologica, September 2017, Wiley

    Mats Lilja, Dr Staffan Rosenborg

  7. Experiences from using LC-MS/MS for analysis of immunosuppressive drugs in a TDM service

    Article • Clinical Biochemistry, September 2016, Elsevier

    Dr Staffan Rosenborg

  8. Ecological Effect of Solithromycin on Normal Human Oropharyngeal and Intestinal Microbiota

    Article • Antimicrobial Agents and Chemotherapy, May 2016, ASM Journals

    Prof Andrej Weintraub, Dr Staffan Rosenborg

  9. First report on the pharmacokinetics of tramadol and O-desmethyltramadol in exhaled breath compared to plasma and oral fluid after a single oral dose

    Article • Biochemical Pharmacology, December 2015, Elsevier

    Dr Staffan Rosenborg

  10. Ecological effect of ceftazidime/avibactam on the normal human intestinal microbiota

    Article • International Journal of Antimicrobial Agents, July 2015, Elsevier

    Dr Staffan Rosenborg

  11. Ecological Effect of Ceftaroline-Avibactam on the Normal Human Intestinal Microbiota

    Article • Antimicrobial Agents and Chemotherapy, May 2015, ASM Journals

    Dr Staffan Rosenborg

  12. Ecological Effect of Ceftaroline/Avibactam on the Normal Human Intestinal Microbiota

    Article • Open Forum Infectious Diseases, January 2015, Oxford University Press (OUP)

    Dr Staffan Rosenborg

  13. High Phenobarbital Clearance During Continuous Renal Replacement Therapy

    Article • Medicine, August 2014, Wolters Kluwer Health

    Dr Staffan Rosenborg

  14. Systematic conversion to generic tacrolimus in stable kidney transplant recipients

    Article • Clinical Kidney Journal, March 2014, Oxford University Press (OUP)

    Dr Staffan Rosenborg

  15. New potential cell source for hepatocyte transplantation: Discarded livers from metabolic disease liver transplants

    Article • Stem Cell Research, July 2013, Elsevier

    Dr Staffan Rosenborg

  16. Characteristics and apprehensions of clinical pharmacologists in Swedish healthcare—a questionnaire study

    Article • European Journal of Clinical Pharmacology, May 2013, Springer Science + Business Media

    Dr Staffan Rosenborg

  17. Quantification of Tacrolimus and Three Demethylated Metabolites in Human Whole Blood Using LC–ESI–MS/MS

    Article • Therapeutic Drug Monitoring, April 2012, Wolters Kluwer Health

    Dr Staffan Rosenborg

  18. Omeprazole limited sampling strategies to predict area under the concentration–time curve ratios: implications for cytochrome P450 2C19 and 3A phenotyping

    Article • European Journal of Clinical Pharmacology, October 2011, Springer Science + Business Media

    Dr Staffan Rosenborg

  19. Clinically Significant CYP2C Inhibition by Noscapine but Not by Glucosamine

    Article • Clinical Pharmacology & Therapeutics, July 2010, Nature

    Dr Staffan Rosenborg

  20. Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects

    Article • European Journal of Clinical Pharmacology, July 2008, Springer Science + Business Media

    Dr Staffan Rosenborg

  21. Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers

    Article • British Journal of Clinical Pharmacology, May 2008, Wiley

    Dr Staffan Rosenborg

  22. Noscapine may increase the effect of warfarin

    Article • British Journal of Clinical Pharmacology, February 2008, Wiley

    Dr Staffan Rosenborg

  23. Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C9*3

    Article • Clinical Pharmacology & Therapeutics, March 2006, Nature

    Dr Staffan Rosenborg

  24. Persistent B19 parvovirus infection in pediatric malignancies

    Article • Medical and Pediatric Oncology, August 1998, Wiley

    Dr Staffan Rosenborg

  25. Persistent B19 parvovirus infection in pediatric malignancies

    Article • Medical and Pediatric Oncology, August 1998, Wiley

    Dr Staffan Rosenborg

  26. Immune Responses to the HIV rev Regulatory Gene

    Article • Karger Publishers

    Dr Staffan Rosenborg